Approvals/NMPA/Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58）Vaccine

Approved

生物制品

Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58）Vaccine

Merck, Inc.🇨🇳 National Medical Products Administration

Approval Id: 1xpZySHmGuS
Approval Number: 国药准字SJ20180008
Generic Name: 九价人乳头瘤病毒疫苗(酿酒酵母)
Generic Name En: Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58）Vaccine
Trade Name: 佳达修9
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 0.5mL/支（预填充注射器）
Reg Date: 2024-01-05
Expired Date: 2028-03-30
Company Name: Merck, Inc.
Company Detail Path: /organization/merck-inc

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 5, 2024

Approval ID

1xpZySHmGuS

Type

生物制品